Fucoxanthin: A Marine Carotenoid Exerting Anti-Cancer Effects by Affecting Multiple Mechanisms

被引:166
作者
Kumar, Sangeetha Ravi [1 ]
Hosokawa, Masashi [1 ]
Miyashita, Kazuo [1 ]
机构
[1] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan
来源
MARINE DRUGS | 2013年 / 11卷 / 12期
基金
日本学术振兴会;
关键词
anti-proliferative; apoptosis; carotenoid; cell cycle arrest; fucoxanthin; BROWN-ALGAE FUCOXANTHIN; PREGNANE X RECEPTOR; CELL-CYCLE ARREST; NF-KAPPA-B; GAP JUNCTIONAL COMMUNICATION; HUMAN HEPATOMA HEPG2; GENE-EXPRESSION; DEACETYLATED PRODUCT; INDUCE APOPTOSIS; DRUG-RESISTANCE;
D O I
10.3390/md11125130
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Fucoxanthin is a marine carotenoid exhibiting several health benefits. The anti-cancer effect of fucoxanthin and its deacetylated metabolite, fucoxanthinol, is well documented. In view of its potent anti-carcinogenic activity, the need to understand the underlying mechanisms has gained prominence. Towards achieving this goal, several researchers have carried out studies in various cell lines and in vivo and have deciphered that fucoxanthin exerts its anti-proliferative and cancer preventing influence via different molecules and pathways including the Bcl-2 proteins, MAPK, NFB, Caspases, GADD45, and several other molecules that are involved in either cell cycle arrest, apoptosis, or metastasis. Thus, in addition to decreasing the frequency of occurrence and growth of tumours, fucoxanthin has a cytotoxic effect on cancer cells. Some studies show that this effect is selective, i.e., fucoxanthin has the capability to target cancer cells only, leaving normal physiological cells unaffected/less affected. Hence, fucoxanthin and its metabolites show great promise as chemotherapeutic agents in cancer.
引用
收藏
页码:5130 / 5147
页数:18
相关论文
共 77 条
[1]   Bcl-2-regulated apoptosis: mechanism and therapeutic potential [J].
Adams, Jerry M. ;
Cory, Suzanne .
CURRENT OPINION IN IMMUNOLOGY, 2007, 19 (05) :488-496
[2]   Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: Formation and cytotoxicity of fucoxanthin metabolites [J].
Asai, A ;
Sugawara, T ;
Ono, H ;
Nagao, A .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (02) :205-211
[3]   Low bioavailability of dietary epoxyxanthophylls in humans [J].
Asai, Akira ;
Yonekura, Lina ;
Nagao, Akihiko .
BRITISH JOURNAL OF NUTRITION, 2008, 100 (02) :273-277
[4]   Lycopene oxidation product enhances gap junctional communication [J].
Aust, O ;
Ale-Agha, N ;
Zhang, L ;
Wollersen, H ;
Sies, H ;
Stahl, W .
FOOD AND CHEMICAL TOXICOLOGY, 2003, 41 (10) :1399-1407
[5]   Biochemical Mechanisms of Cisplatin Cytotoxicity [J].
Cepeda, Victoria ;
Fuertes, Miguel A. ;
Castilla, Josefina ;
Alonso, Carlos ;
Quevedo, Celia ;
Perez, Jose M. .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2007, 7 (01) :3-18
[6]   In vitro antioxidant activities of three selected brown seaweeds of India [J].
Chandini, S. Kumar ;
Ganesan, P. ;
Bhaskar, N. .
FOOD CHEMISTRY, 2008, 107 (02) :707-713
[7]   Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment [J].
Chen, Yakun ;
Nie, Daotai .
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2009, 4 (01) :19-27
[8]   Marine algal fucoxanthin inhibits the metastatic potential of cancer cells [J].
Chung, Tae-Wook ;
Choi, Hee-Jung ;
Lee, Ji-Yeon ;
Jeong, Han-Sol ;
Kim, Cheorl-Ho ;
Joo, Myungsoo ;
Choi, Jun-Yong ;
Han, Chang-Woo ;
Kim, So-Yeon ;
Choi, Jae-Sue ;
Ha, Ki-Tae .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 439 (04) :580-585
[9]   Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress [J].
Cowan, KJ ;
Storey, KB .
JOURNAL OF EXPERIMENTAL BIOLOGY, 2003, 206 (07) :1107-1115
[10]   Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1 [J].
Das, SK ;
Hashimoto, T ;
Shimizu, K ;
Yoshida, T ;
Sakai, T ;
Sowa, Y ;
Komoto, A ;
Kanazawa, K .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2005, 1726 (03) :328-335